Zhenghao Zhao

Title: Innovations of Zhenghao Zhao in Recombinant Human Adenovirus Research

Introduction

Zhenghao Zhao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of vector systems for gene therapy and vaccine preparation. His innovative work has the potential to impact various medical applications.

Latest Patents

Zhenghao Zhao holds a patent for a "Single plasmid vector system for packaging recombinant human adenovirus type 4 and application thereof." This invention involves a single plasmid vector system designed for the efficient packaging of recombinant human adenovirus type 4. The system includes an E3 region-deleted human adenovirus type 4 genome, a vector sequence for amplifying plasmids in bacteria, a pBR322 replication origin, a kanamycin resistance gene, and a replication control sequence. An exogenous gene embedding site is strategically located behind a packaging signal of the human adenovirus type 4 and in front of an E1 region. This invention also outlines a method for packaging the recombinant human adenovirus type 4 using the single plasmid vector system, which has promising applications in vaccine and drug preparation.

Career Highlights

Zhenghao Zhao is affiliated with the Academy of Military Medical Science, PLA. His work focuses on developing innovative solutions for gene therapy and vaccine production, showcasing his commitment to advancing medical science.

Collaborations

Zhenghao Zhao has collaborated with notable colleagues, including Wei Chen and Busen Wang. Their combined expertise contributes to the success of their research endeavors.

Conclusion

Zhenghao Zhao's innovative contributions to the field of recombinant human adenovirus research highlight his role as a leading inventor in biotechnology. His work not only advances scientific knowledge but also holds significant promise for future medical applications.